PETRIOLI, ROBERTO
 Distribuzione geografica
Continente #
NA - Nord America 343
EU - Europa 200
AS - Asia 35
SA - Sud America 4
AF - Africa 1
Totale 583
Nazione #
US - Stati Uniti d'America 342
IT - Italia 78
SE - Svezia 30
IE - Irlanda 26
GB - Regno Unito 17
FR - Francia 15
VN - Vietnam 15
DE - Germania 11
JP - Giappone 10
CN - Cina 6
MK - Macedonia 5
CL - Cile 4
NL - Olanda 3
UA - Ucraina 3
CZ - Repubblica Ceca 2
RS - Serbia 2
RU - Federazione Russa 2
SG - Singapore 2
CA - Canada 1
CH - Svizzera 1
DK - Danimarca 1
ES - Italia 1
FI - Finlandia 1
IN - India 1
LU - Lussemburgo 1
RO - Romania 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 583
Città #
Siena 54
Santa Cruz 36
Fairfield 31
Stockholm 30
Dublin 25
Houston 22
Ashburn 21
Ann Arbor 18
Buffalo 17
Seattle 17
Dong Ket 15
Southend 12
Chicago 10
Woodbridge 10
Cambridge 8
Tokyo 8
Wilmington 6
Los Angeles 4
Philadelphia 4
San Francisco 4
Cittaducale 3
Florence 3
Kansas City 3
Las Vegas 3
New York 3
Struga 3
Council Bluffs 2
Crugers 2
Fleming Island 2
Guangzhou 2
Lahontan 2
Milpitas 2
Novi Sad 2
Phoenix 2
Prato 2
Providence 2
Saint Petersburg 2
San Diego 2
Santiago 2
Singapore 2
Teano 2
Voorburg 2
Adana 1
Alicante 1
Athis-mons 1
Boardman 1
Bochum 1
Boiling Springs 1
Büdelsdorf 1
Carsoli 1
Chandler 1
Changzhou 1
Clearwater 1
Dulles 1
Frankfurt am Main 1
Gunzenhausen 1
Helsinki 1
Hillsboro 1
Honolulu 1
Ibaraki 1
Kyiv 1
Lincoln 1
London 1
Luxembourg 1
Lviv 1
Martellago 1
Milan 1
Montreuil 1
Muizenberg 1
Nashville 1
Omaha 1
Ottawa 1
Parlin 1
Rhyl 1
Riva 1
Rome 1
San Jose 1
Scranton 1
Strumica 1
Suita 1
University Park 1
Vaglia 1
Wuhan 1
Zurich 1
Totale 444
Nome #
The prognostic value of CD3+ tumor-infiltrating lymphocytes for stage II colon cancer according to use of adjuvant chemotherapy: A large single-institution cohort study: TILs for ADJ-untreated stage II colon cancer, file e0feeaa9-7ecb-44d2-e053-6605fe0a8db0 140
null, file e0feeaa5-10d9-44d2-e053-6605fe0a8db0 111
Preoperative or perioperative docetaxel, oxaliplatin, and capecitabine (GASTRODOC regimen) in patients with locally-advanced resectable gastric cancer: A randomized phase-II trial, file e0feeaa9-8e50-44d2-e053-6605fe0a8db0 86
Two-point-NGS analysis of cancer genes in cell-free DNA of metastatic cancer patients, file e0feeaa8-527c-44d2-e053-6605fe0a8db0 69
A case of eribulin-induced regression of liposarcoma of the left funiculus in a heavily pretreated patient, file e0feeaa9-2d67-44d2-e053-6605fe0a8db0 60
Association of Concomitant Bone Resorption Inhibitors with Overall Survival among Patients with Metastatic Castration-Resistant Prostate Cancer and Bone Metastases Receiving Abiraterone Acetate with Prednisone as First-Line Therapy, file e0feeaaa-ef6c-44d2-e053-6605fe0a8db0 44
Efficacy and Safety of Regorafenib With 2/1 Schedule for Patients ≥ 75 Years With Metastatic Colorectal Cancer (mCRC) After Failure of 2 Lines of Chemotherapy, file e0feeaab-b487-44d2-e053-6605fe0a8db0 39
A husband and a wife with simultaneous presentation of glioblastoma multiforme: a case report, file e0feeaa8-9b56-44d2-e053-6605fe0a8db0 12
CEA and CA19.9 as early predictors of progression in advanced/metastatic colorectal cancer patients receiving oxaliplatin-based chemotherapy and bevacizumab, file e0feeaa5-aab8-44d2-e053-6605fe0a8db0 5
C-Met targeting in advanced gastric cancer: An open challenge, file e0feeaa5-746b-44d2-e053-6605fe0a8db0 3
Angiogenesis inhibitors in gastric and gastroesophageal junction cancer, file e0feeaa5-be1e-44d2-e053-6605fe0a8db0 3
Strong Prognostic Value of Microsatellite Instability in Intestinal Type Non-cardia Gastric Cancer, file e0feeaa5-bf0f-44d2-e053-6605fe0a8db0 3
Gemcitabine plus nab-paclitaxel followed by maintenance treatment with gemcitabine alone as first-line treatment for older adults with locally advanced or metastatic pancreatic cancer, file e0feeaa8-7a9f-44d2-e053-6605fe0a8db0 3
null, file e0feeaa4-f5c8-44d2-e053-6605fe0a8db0 2
Gastric cancer: Current status of lymph node dissection, file e0feeaa5-be26-44d2-e053-6605fe0a8db0 2
null, file e0feeaa5-be27-44d2-e053-6605fe0a8db0 2
null, file e0feeaa5-be29-44d2-e053-6605fe0a8db0 2
Monoclonal antibodies-based treatment in gastric cancer: current status and future perspectives, file e0feeaa5-c626-44d2-e053-6605fe0a8db0 2
Short-term and long-term risk factors in gastric cancer, file e0feeaa5-82a8-44d2-e053-6605fe0a8db0 1
Maintenance treatment with oral cyclophosphamide and bevacizumab in patients with recurrent epithelial ovarian cancer, file e0feeaa5-bd7b-44d2-e053-6605fe0a8db0 1
Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experience, file e0feeaa5-bdef-44d2-e053-6605fe0a8db0 1
Treatment of advanced oesophagogastric cancer with FOLFOX-4 regimen followed by leucovorin/bolus and continuous infusion 5-FU as maintenance chemotherapy in patients aged ≥ 75 years with impaired performance status, file e0feeaa5-bdf0-44d2-e053-6605fe0a8db0 1
null, file e0feeaa5-bdf4-44d2-e053-6605fe0a8db0 1
null, file e0feeaa5-bdf6-44d2-e053-6605fe0a8db0 1
null, file e0feeaa5-be21-44d2-e053-6605fe0a8db0 1
Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer, file e0feeaa5-be52-44d2-e053-6605fe0a8db0 1
null, file e0feeaa5-d7e9-44d2-e053-6605fe0a8db0 1
null, file e0feeaa5-d83a-44d2-e053-6605fe0a8db0 1
Pathological response and outcome after neoadjuvant chemotherapy with DOC (docetaxel, oxaliplatin, capecitabine) or EOF (epirubicin, oxaliplatin, 5-fluorouracil) for clinical T3-T4 non-metastatic gastric cancer, file e0feeaa8-91c2-44d2-e053-6605fe0a8db0 1
Capecitabine Plus Oxaliplatin and Bevacizumab, Followed by Maintenance Treatment With Capecitabine and Bevacizumab for Patients Aged > 75 Years With Metastatic Colorectal Cancer, file e0feeaa8-afce-44d2-e053-6605fe0a8db0 1
Gemcitabine plus nab-paclitaxel followed by maintenance treatment with gemcitabine alone as first-line treatment for older adults with locally advanced or metastatic pancreatic cancer, file e0feeaaa-55ed-44d2-e053-6605fe0a8db0 1
Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials, file e0feeaab-06dd-44d2-e053-6605fe0a8db0 1
Totale 602
Categoria #
all - tutte 1.683
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.683


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201918 0 0 0 0 0 0 0 0 2 4 6 6
2019/202042 5 4 1 4 3 3 3 8 4 2 5 0
2020/2021102 2 1 2 0 3 5 18 15 5 16 10 25
2021/2022151 5 6 7 19 17 9 8 5 9 6 48 12
2022/2023179 10 10 36 27 10 21 5 32 13 4 10 1
2023/202476 16 5 2 18 8 13 14 0 0 0 0 0
Totale 602